This patent covers the composition of matter of several polypeptides and compounds that can activate the granulocyte colony stimulating factor receptor. These compounds can be developed into therapeutic agents for similar indications such those treated by Amgen's Neupogen.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.